These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 26060603)

  • 21. Missed opportunities for prevention of perinatal transmission of hepatitis B: a retrospective cohort study.
    van Schalkwyk J; Nourmoussavi M; Massey A; Gustafson R; Brodkin E; Petric M; Krajden M; Dobson S; Buxton J; Bigham M; Pick N; Schreiber R; Sherlock CH; Money D; Yoshida EM
    Can J Gastroenterol Hepatol; 2014 Nov; 28(10):525-8. PubMed ID: 25390612
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serological positive markers of hepatitis B virus in femoral venous blood or umbilical cord blood should not be evidence of in-utero infection among neonates.
    Zhang L; Gui XE; Wang B; Fan JY; Cao Q; Mullane K; Liang XL
    BMC Infect Dis; 2016 Aug; 16(1):408. PubMed ID: 27515176
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of maternal screening and universal immunization to prevent mother-to-infant transmission of HBV.
    Chen HL; Lin LH; Hu FC; Lee JT; Lin WT; Yang YJ; Huang FC; Wu SF; Chen SC; Wen WH; Chu CH; Ni YH; Hsu HY; Tsai PL; Chiang CL; Shyu MK; Lee PI; Chang FY; Chang MH
    Gastroenterology; 2012 Apr; 142(4):773-781.e2. PubMed ID: 22198276
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gaps in the prevention of perinatal transmission of hepatitis B virus between recommendations and routine practices in a highly endemic region: a provincial population-based study in China.
    Hu Y; Zhang S; Luo C; Liu Q; Zhou YH
    BMC Infect Dis; 2012 Sep; 12():221. PubMed ID: 22984924
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risk factors associated with immunoprophylaxis failure against mother to child transmission of hepatitis B virus and hepatitis B vaccination status in Yunnan province, China.
    Kang W; Ding Z; Shen L; Zhao Z; Huang G; Zhang J; Xiong Q; Zhang S; Zhang S; Wang F
    Vaccine; 2014 Jun; 32(27):3362-6. PubMed ID: 24793939
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Is the use of Tenofovir Dipivoxil fumarate effective and safe in preventing vertical transmission in pregnant women with chronic HBV with high viral load?
    Aladag H; Aladag M
    Eur Rev Med Pharmacol Sci; 2023 Mar; 27(5):2091-2098. PubMed ID: 36930508
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Maternal hepatitis B e antigen can be an indicator for antiviral prophylaxis of perinatal transmission of hepatitis B virus.
    Lu Y; Song Y; Zhai X; Zhu F; Liu J; Chang Z; Li Y; Xiao Y; Li L; Liu M; Liu J; Duan Z; Zou H; Zhuang H; Wang J; Li J
    Emerg Microbes Infect; 2021 Dec; 10(1):555-564. PubMed ID: 33682609
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combined passive and active immunoprophylaxis for preventing perinatal transmission of the hepatitis B virus carrier state in Shizuoka, Japan during 1980-1994.
    Noto H; Terao T; Ryou S; Hirose Y; Yoshida T; Ookubo H; Mito H; Yoshizawa H;
    J Gastroenterol Hepatol; 2003 Aug; 18(8):943-9. PubMed ID: 12859724
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevention of mother-to-child transmission of hepatitis B virus: a phase III, placebo-controlled, double-blind, randomized clinical trial to assess the efficacy and safety of a short course of tenofovir disoproxil fumarate in women with hepatitis B virus e-antigen.
    Jourdain G; Ngo-Giang-Huong N; Cressey TR; Hua L; Harrison L; Tierney C; Salvadori N; Decker L; Traisathit P; Sirirungsi W; Khamduang W; Bowonwatanuwong C; Puthanakit T; Siberry GK; Watts DH; Murphy TV; Achalapong J; Hongsiriwon S; Klinbuayaem V; Thongsawat S; Chung RT; Pol S; Chotivanich N
    BMC Infect Dis; 2016 Aug; 16():393. PubMed ID: 27506549
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The association between maternal hepatitis B e antigen status, as a proxy for perinatal transmission, and the risk of hepatitis B e antigenaemia in Gambian children.
    Shimakawa Y; Bottomley C; Njie R; Mendy M
    BMC Public Health; 2014 May; 14():532. PubMed ID: 24885392
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A prospective and open-label study for the efficacy and safety of telbivudine in pregnancy for the prevention of perinatal transmission of hepatitis B virus infection.
    Han GR; Cao MK; Zhao W; Jiang HX; Wang CM; Bai SF; Yue X; Wang GJ; Tang X; Fang ZX
    J Hepatol; 2011 Dec; 55(6):1215-21. PubMed ID: 21703206
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effectiveness of prevention of mother-to-child transmission practice in three provinces of Southern China.
    Wang F; Zheng H; Zhang G; Ding Z; Li F; Zhong G; Chen Y; Jia Y; Miao N; Wu Z; Sun X; Li L; Liang X; Cui F
    Hum Vaccin Immunother; 2015; 11(8):2061-7. PubMed ID: 26090956
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Factors associated with vaccine failure and vertical transmission of hepatitis B among a cohort of Canadian mothers and infants.
    Singh AE; Plitt SS; Osiowy C; Surynicz K; Kouadjo E; Preiksaitis J; Lee B
    J Viral Hepat; 2011 Jul; 18(7):468-73. PubMed ID: 20546502
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increased Protection of Earlier Use of Immunoprophylaxis in Preventing Perinatal Transmission of Hepatitis B Virus.
    Huang H; Xu C; Liu L; Chen L; Zhu X; Chen J; Feng J; Chen T; Xu B; Yang J; Xu B; Pan M; Dai Y; Hu Y; Zhou YH
    Clin Infect Dis; 2021 Nov; 73(9):e3317-e3323. PubMed ID: 32634824
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Factors associated with immunoprophylaxis failure against vertical transmission of hepatitis B virus.
    Song YM; Sung J; Yang S; Choe YH; Chang YS; Park WS
    Eur J Pediatr; 2007 Aug; 166(8):813-8. PubMed ID: 17120036
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of elective cesarean section on the risk of mother-to-child transmission of hepatitis B virus.
    Hu Y; Chen J; Wen J; Xu C; Zhang S; Xu B; Zhou YH
    BMC Pregnancy Childbirth; 2013 May; 13():119. PubMed ID: 23706093
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Post-vaccination serologic testing of infants born to hepatitis B surface antigen positive mothers in 4 provinces of China.
    Wang F; Zhang G; Zheng H; Miao N; Shen L; Wang F; Dong P; Du F; Chen C; Zhang X; Cui F
    Vaccine; 2017 Jul; 35(33):4229-4235. PubMed ID: 28651839
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hepatitis B virus infection.
    Chang MH
    Semin Fetal Neonatal Med; 2007 Jun; 12(3):160-7. PubMed ID: 17336170
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevention of perinatal hepatitis B virus transmission in the Netherlands, 2003-2007: children of Chinese mothers are at increased risk of breakthrough infection.
    Hahné S; van den Hoek A; Baayen D; van der Sande M; de Melker H; Boot H
    Vaccine; 2012 Feb; 30(9):1715-20. PubMed ID: 22210140
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Abstract efficacy of combined vaccine for the prevention of HBV transmission in highly viremic HBeAg+ mothers and the HBV markers' dynamic change of babies in follow-up].
    Jiang HX; Han GR; Wang CM; Yue X; Wang GJ
    Zhonghua Gan Zang Bing Za Zhi; 2011 Nov; 19(11):818-22. PubMed ID: 22433302
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.